Quick Answer
NEOGEN CORP reported Total Revenue of $894.66 million for the year ending 2025.
- NEOGEN CORP showed a decrease of -3.2% in Total Revenue from 2024 to 2025.
- This data is from NEOGEN CORP's annual report (Form 10-K), filed with the SEC on July 30, 2025.
- XBRL data for this metric is available from 2016 to 2025 (10 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2017: $94.21 million | Q4 2017: $100.70 million | Q1 2018: $94.90 million | Q3 2018: $99.63 million | Q4 2018: $107.10 million | Q1 2019: $97.70 million | Q3 2019: $101.42 million | Q4 2019: $107.80 million | Q1 2020: $99.87 million | Q3 2020: $109.33 million | Q4 2020: $115.00 million | Q1 2021: $116.71 million | Q3 2021: $128.31 million | Q4 2021: $130.52 million | Q1 2022: $128.24 million | Q3 2022: $132.35 million | Q4 2022: $230.03 million | Q1 2023: $218.26 million | Q3 2023: $228.99 million | Q4 2023: $229.63 million | Q1 2024: $228.81 million | Q3 2024: $216.96 million | Q4 2024: $231.26 million | Q1 2025: $220.98 million | Q3 2025: $209.19 million | Q4 2025: $224.69 million.
- Over the full 10 years of available data (2016 to 2025), NEOGEN CORP's Total Revenue has grown by 178.5%.
- Historical annual values: Fiscal year 2025: $894.66 million | Fiscal year 2024: $924.22 million | Fiscal year 2023: $822.45 million | Fiscal year 2022: $527.16 million | Fiscal year 2021: $468.46 million | Fiscal year 2020: $418.17 million | Fiscal year 2019: $414.19 million | Fiscal year 2018: $397.93 million | Fiscal year 2017: $358.28 million | Fiscal year 2016: $321.28 million.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: